**About the Editor**

**Hiroshi Sakagami** was born in Tokyo (1952), and got his Ph.D. from Faculty of Pharmaceutical Sciences, University of Tokyo (1980). He worked for 17 years in Department of Biochemistry, School of Medicine, Showa University, Tokyo, with a 3 year stay as visiting researcher in Roswell Park Memorial Institute, Buffalo, NY (under the direction of Dr. Bloch). He became the professor of Division of Pharmacology, Meikai University School of Dentistry (1997) and the director of industry-supported Meikai Pharmaco-Medical Laboratory (MPL) (1999). He became the professor of Meikai University Research Institute of Odontology (M-RIO) (2017). His research interest includes the biological function of lignin-carbohydrate complex, application of plant extracts to oral diseases, exploration of anticancer drugs that has least keratinocyte toxicity and neurotoxicity, and creation of new field of research by international collaboration, resulting in the discovery of new anticancer drug candidates, such as chromone derivatives and α,β-unsaturated ketones (with Drs. Sugita, Takao, Gul and Dimmock). He was the principal investigator for 8 Grant-in-Aids from the Ministry of Education, Science, Sports and Culture of Japan. He is also the directors of board of the trustees for both Meikai and Asahi University. He is an editor of *Medicines*, and board member of *New Food Industry* and *In Vivo*.
